ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Semaglutide may help people with obesity lose weight
March 22, 2018A compound that mimics a naturally occurring hormone that regulates appetite may help people who have obesity but not diabetes to lose weight… -
Novo Nordisk’s diabetes pill presents the first successful data
February 27, 2018The oral form of the drug, known generically as semaglutide, is crucial for ensuring the group's long-term growth, as price pressure mounts in a crowded market targeting the world's 450 million diabetics. -
Semaglutide Demonstrated Significant Reductions in Blood Sugar and Weight Compared with Dulaglutide;
February 02, 2018The Lancet Diabetes and Endocrinology has published the results of the SUSTAIN 7 trial -
Oral semaglutide shows promise for type 2 diabetes
October 18, 2017Researchers have identified that the drug semaglutide resulted in better glycemic control than placebo for patients with type 2 diabetes… -
Novo’s semaglutide superior to Lilly’s Trulicity in diabetes trial
August 18, 2017Novo Nordisk’s once-weekly diabetes drug semaglutide has beaten Eli Lilly’s once-weekly therapy dulaglutide on reducing blood sugar and weight in patients taking part in a late-stage trial.
Pharma Sources Insight January 2025
